臨床試驗

Enterprise 2 Vascular Reconstruction Device

NCT：NCT05254067 · COMPLETED

NCT IDNCT05254067

狀態COMPLETED

開始日期2017-02-28

完成時間2026-01-05

SponsorMethodist Health System (OTHER)

First posted2022-02-24

Last updated2026-05-18

簡要摘要

The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。